Lara Roberts

Has grant

Honorary Professor of Haemostasis and Thrombosis

King's College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Lara Roberts is an Honorary Professor of Haemostasis and Thrombosis at King's College London, UK. Her research focuses on venous thromboembolism, pulmonary embolism, and the management of coagulopathies, as evidenced by her recent articles. Dr. Roberts has contributed to the understanding of thromboprophylaxis in ambulatory patients and the complexities of chronic hepatitis B treatments.

Recent Grants

Grant: Open

Apixaban to Prevent dEcompensation of eArly liver CirrHosis (APEACH)

Open Date: 2025-06-01

Close Date: 2030-11-30

Grant: Open

Short-term low-dose low-molecular-weight heparin to prevent postpartum thrombosis: a pragmatic, multi-center, open-label randomized controlled trial

Open Date: 2025-04-01

Close Date: 2030-03-31

Grant: Open

The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial

Open Date: 2025-03-01

Close Date: 2027-02-28

Grant: Close

Haemostasis in critically ill patients with advanced chronic liver disease

Open Date: 2022-11-25

Close Date: 2025-11-24

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (1)

Jignesh Patel

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lara Roberts

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Purpura Fulminans: A Dermatological Emergency Revisited.

Pulmonary embolism diagnosis and the D-dilemma.

Is pulmonary embolism a chronic disease?

Basics of diagnosis and treatment of venous thromboembolism.

Moving medical management to community care: time to consider thromboprophylaxis for "ambulatory" patients?

Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? – A population pharmacokinetic analysis

Disseminated intravascular coagulation and cirrhotic coagulopathy: overlap and differences. The current state of knowledge. Communication from the SSC of the ISTH.

Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy.

King's lower limb immobilisation VTE risk assessment tool (K4 score) in conservatively treated ambulatory patients: a 2-year review.

Prevention and management of venous thrombosis in patients with cirrhosis.

Collaborators (1)

Jignesh Patel

Make your next move.